Wound care
References 1. Broughton, G., Janis, J.E. and Attinger, C.E. A brief history of wound care, Plastic and Reconstructive Surgery, 2006, 117(7 Suppl), pp. 6S–11S. doi: 10.1097/01. prs.0000225429.76355.dd.
2. Helling, T.S. and McNabney, W.K. The role of amputation in the management of battlefield casualties: a history of two millennia, Journal of Trauma, 2000, 49(5), pp. 930–939. doi: 10.1097/00005373-200011000- 00022.
3. Mayer, D.O., Tettelbach, W.H., Ciprandi, G., Downie, F., Hampton, J., Hodgson, H., Lazaro-Martinez, J.L., Probst, A., Schultz, G., Stürmer, E.K., Parnham, A., Frescos, N., Stang, D., Holloway, S. and Percival, S.L. Best practice for wound debridement, Journal of Wound Care, 2024, 33(Sup6b), pp. S1–S32. doi: 10.12968/
jowc.2024.33.Sup6b.S1.
4. Nowak, M., Mehrholz, D., Barańska-Rybak, W. and Nowicki, R.J. Wound debridement products and techniques: clinical examples and literature review, Postepy Dermatologii i Alergologii, 2022, 39(3), pp. 479–490. doi: 10.5114/ada.2022.117572.
5. Strohal, R., Dissemond, J., Jordan O’Brien, J., Piaggesi, A., Rimdeika, R., Young, T. and Apelqvist, J. EWMA document: Debridement. An updated overview and clarification of the principle role of debridement, Journal of Wound Care, 2013, 22(1), pp. S1. doi: 10.12968/
jowc.2013.22.Sup1.S1.
6. Staines, K. Tackling hard-to-heal wounds with a new option for chemical debridement, Journal of Wound Care, 2023, 32(Sup3b), pp. S3. doi: 10.12968/
jowc.2023.32.Sup3b.S3.
7. Rajhathy EM, Hill MC, Tran DL, Sibbald RG, Ayello EA. Evidence-Informed Nursing Clinical Practices for Wound Debridement. Am J Nurs, 2024 Dec 1;124(12):26-34. doi: 10.1097/
01.NAJ.0001094536.99329.34. Epub 2024 Nov 21. PMID: 39514029.
8. Murphy, C., et al. Defying hard-to- heal wounds with an early antibiofilm intervention strategy: “wound hygiene”, Journal of Wound Care, 2019, 28(12), pp. 818–822. doi: 10.12968/jowc.2019.28.12.818.
9. Tettelbach, W.H., Cazzell, S.M., Hubbs, B., Jong, J.L., Forsyth, R.A. and Reyzelman, A.M. The influence of adequate debridement and placental-derived allografts on diabetic foot ulcers, Journal of Wound Care, 2022, 31(Sup9), pp. S16–S26. doi: 10.12968/
jowc.2022.31.Sup9.S16.
10. Gray TA, Wilson P, Dumville JC, Cullum NA. What factors influence community wound care in the UK? A focus group study using the Theoretical Domains Framework. BMJ Open. 2019 Jul 31;9(7):e024859. doi: 10.1136/
66
www.clinicalservicesjournal.com I October 2025
bmjopen-2018-024859. PMID: 31371284; PMCID: PMC6678001.
11. National Institute for Health and Care Excellence (NICE). The Debrisoft monofilament debridement pad for use in acute or chronic wounds [MTG17]. 2019. Available at: https://
www.nice.org.uk/Guidance/MTG17.
12. Burnett, J., Kerr, A., Morrison, M. and Ruston, A. An audit to assess the impact of prescribing a monofilament fibre debridement pad for patients with unhealed wounds after six months, Journal of Wound Care, 2021, 30(5).
13. Soares MO, Dumville JC, Ashby RL, Iglesias CP, Stubbs N, Cullum NA. VenUS II: A randomised controlled trial of larval therapy in the management of leg ulcers. Health Technol Assess, 2009, 13(55): 1–182.
14. Bahr, S., et al. Clinical efficacy of a new monofilament fibre-containing wound debridement product, Journal of Wound Care, 2011, 20(5), pp. 242–248. doi: 10.12968/ jowc.2011.20.5.242.
15. External Assessment Centre. Evaluation report for NICE Medical Technologies Guidance MTG17: The Debrisoft monofilament debridement pad for use in acute or chronic wounds. Newcastle University, 2014. Available online:
https://www.nice.org.uk/ guidance/mtg17/resources/the-debrisoft- monofilament-debridement-pad-for- use-in-acute-or-chronic-wounds-external- assessment-centre-assessment-report (accessed 9th June, 2025)
16. Meads, C., Lovato, E. and Longworth, L. The Debrisoft Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance, Applied Health Economics and Health Policy, 2015, 13(6), pp. 583–594. doi: 10.1007/s40258-015-0195-0.
17. Wounds UK Best Practice Statement. Effective exudate management. London: Wounds UK, 2013. Available to download from: www.wounds-
uk.com
About the authors
Andrew Kerr is a Director at Lower Limb Consultancy Services. After qualifying at the University of Brighton in 1999 and beginning his career in a vascular unit, he developed a strong interest in innovation and improving patient outcomes, which led him to specialise in Tissue Viability. With over 25 years of NHS nursing experience and 10 years in combined clinical and commercial roles, he now provides specialist consultancy services that integrate deep clinical expertise with commercial insight to advance wound care and lower limb management. He also holds a Tissue Viability Honorarium at Sandwell and West Birmingham Hospitals NHS Trust, working closely with community services to improve patient outcomes.
Elizabeth Williams BA Hons, BSc Hons Pod, HCPC, is a Diabetic Podiatrist, based at the Royal Devon and Exeter Foundation Trust. She specialises in complex, hard to heal Diabetic Foot Wounds. Elizabeth has been in practice for 21 years and is an experienced speaker, educator and leader within the field of Podiatry. She is passionate about creative initiatives in medical technology which create opportunities for improved outcomes for patients.
Sarah Waller, BA(Hons), PG Cert, is Elysium Health Care’s Tissue Viability Clinical Nurse Specialist, based at Jacobs and Gardens Neurological Centre Sawbridgeworth, Hertfordshire, England. Elysium Health Care is part of Ramsey Health. She specialised in Tissue Viability nine years ago, and has 35 years’ experience within Nursing, starting at Auxiliary. Now with Elysium Health Care, she is grasping the opportunity to help formulate and introduce Tissue Viability within their service – clinically, academically and in leadership.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
